Aigen Investment Management’s Elevance Health ELV Stock Holding History

Aigen Investment Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$702K	Sell	1,816 -11,167	-86%	-$4.14M	0.19%	140
2026 Q1	$3.8M	Buy	+12,983	New	+$4.27M	0.98%	11
2024 Q1	–	Sell	-3,717	Closed	-$1.75M	–	762
2023 Q4	$1.75M	Sell	3,717 -1,968	-35%	-$910K	0.31%	78
2023 Q3	$2.48M	Buy	5,685 +3,484	+158%	+$1.58M	0.47%	19
2023 Q2	$978K	Sell	2,201 -2,612	-54%	-$1.2M	0.14%	207
2023 Q1	$2.21M	Buy	+4,813	New	+$2.29M	0.3%	77
2022 Q4	–	Sell	-17,444	Closed	-$7.92M	–	600
2022 Q3	$7.92M	Buy	17,444 +6,273	+56%	+$3M	1.14%	6
2022 Q2	$5.39M	Buy	+11,171	New	+$5.53M	0.91%	15
2022 Q1	–	Sell	-2,765	Closed	-$1.24M	–	696
2021 Q4	$1.24M	Buy	+2,765	New	+$1.16M	0.08%	350
2021 Q2	–	Sell	-2,729	Closed	-$980K	–	546
2021 Q1	$980K	Buy	+2,729	New	+$878K	0.13%	181
2020 Q4	–	Sell	-1,508	Closed	-$405K	–	839
2020 Q3	$405K	Sell	1,508 -9,697	-87%	-$2.61M	0.05%	448
2020 Q2	$2.95M	Buy	11,205 +350	+3%	+$93.4K	0.38%	48
2020 Q1	$2.46M	Buy	+10,855	New	+$2.96M	0.33%	63

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Aigen Investment Management's ELV Position: Q2 2026 in Review

Aigen Investment Management reduced its Elevance Health (ELV) stake by 86% in Q2 2026, selling an estimated $4.14M and leaving 1,816 shares worth $702K. The position accounts for 0.19% of the portfolio, ranked #140.

Aigen Investment Management first reported a position in ELV in Q1 2020 and has held it in 13 quarters since. The position peaked at $7.92M in Q3 2022. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Aigen Investment Management held 1,816 shares of Elevance Health worth $702K as of Q2 2026.
Aigen Investment Management sold 11,167 Elevance Health shares in Q2 2026, an estimated $4.14M.
Elevance Health made up 0.19% of Aigen Investment Management's portfolio in Q2 2026, its #140 holding.
Aigen Investment Management first reported a position in Elevance Health in Q1 2020 and has held it in 13 quarters since.
Aigen Investment Management's Elevance Health position peaked at $7.92M in Q3 2022.
1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Aigen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.